The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy.

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

orforglipron Eli Lilly competitor Novo Nordisk kicked off the weight-loss drug craze when it started selling Ozempic in the US in 2017. Back then, the once-weekly drug was only approved to treat ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

There is only one GLP-1 pill on the market, and it's not as effective as Ozempic for weight loss.Grace Cary/Getty Images Eli Lilly competitor Novo Nordisk kicked off the weight-loss drug craze ...

which include Ozempic for diabetes and Wegovy for weight loss. The company said it's exploring the use of semaglutide, a type of GLP-1, for other diseases such as chronic kidney disease ...

The Food and Drug Administration's approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1. Today ...

Game-changing weight loss jabs relied on by millions of slimmers ... The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era in the battle against obesity, helping dieters ...